Xiaoming Xu

1.3k total citations
49 papers, 1.0k citations indexed

About

Xiaoming Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoming Xu has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoming Xu's work include Cancer-related molecular mechanisms research (6 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Barrier Structure and Function Studies (5 papers). Xiaoming Xu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Barrier Structure and Function Studies (5 papers). Xiaoming Xu collaborates with scholars based in China, United States and Ethiopia. Xiaoming Xu's co-authors include Huafeng Pan, Rui Xin, Chengshi Quan, Yafang Liu, Qiong Wu, Jinlong Tang, Honghe Zhang, Yuan Li, Jingyu Wang and Na Li and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Xiaoming Xu

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoming Xu China 17 530 297 199 134 114 49 1.0k
Fanen Yuan China 20 639 1.2× 407 1.4× 148 0.7× 210 1.6× 144 1.3× 50 1.1k
Maria Concetta Faniello Italy 22 719 1.4× 361 1.2× 182 0.9× 194 1.4× 76 0.7× 55 1.2k
Galina Khramtsova United States 16 844 1.6× 272 0.9× 438 2.2× 101 0.8× 181 1.6× 34 1.5k
Nikki P.Y. Lee Hong Kong 26 1.2k 2.3× 374 1.3× 273 1.4× 96 0.7× 118 1.0× 34 2.4k
Wenzhi Shen China 23 781 1.5× 421 1.4× 333 1.7× 208 1.6× 257 2.3× 62 1.4k
Krzysztof Goryca Poland 19 762 1.4× 326 1.1× 283 1.4× 217 1.6× 128 1.1× 69 1.3k
Zhihui Min China 19 442 0.8× 222 0.7× 366 1.8× 132 1.0× 424 3.7× 42 1.2k
Elham Baghbani Iran 19 756 1.4× 487 1.6× 275 1.4× 131 1.0× 190 1.7× 55 1.2k
Han Yang China 28 933 1.8× 571 1.9× 365 1.8× 162 1.2× 300 2.6× 71 1.7k
Ajay K. Yadav India 15 587 1.1× 281 0.9× 173 0.9× 57 0.4× 103 0.9× 40 968

Countries citing papers authored by Xiaoming Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Xu more than expected).

Fields of papers citing papers by Xiaoming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Xu. The network helps show where Xiaoming Xu may publish in the future.

Co-authorship network of co-authors of Xiaoming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Xu. A scholar is included among the top collaborators of Xiaoming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Xu. Xiaoming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaoming, et al.. (2025). Apigenin protects ischemic stroke by regulating intestinal microbiota homeostasis, regulates brain metabolic profile. Frontiers in Pharmacology. 16. 1553081–1553081. 1 indexed citations
2.
3.
Qiu, Yuangang, et al.. (2025). Cancer-associated fibroblasts: multidimensional players in liver cancer. Frontiers in Oncology. 15. 1454546–1454546. 2 indexed citations
4.
Xie, Yangli, Dandan Geng, Jingran Li, et al.. (2025). Restoration of mitochondrial energy metabolism by electroconvulsive therapy in adolescent and juvenile mice. Frontiers in Psychiatry. 16. 1555144–1555144. 1 indexed citations
5.
6.
Chen, Zhigang, et al.. (2023). Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets. Nature Communications. 14(1). 3469–3469. 5 indexed citations
7.
Xu, Xiaoming & Jingzhi Wang. (2023). Multi-omics analysis reveals focal adhesion characteristic associated tumor immune microenvironment in colon adenocarcinoma. Frontiers in Genetics. 14. 1088091–1088091. 2 indexed citations
8.
Chen, Chao, Xiaoming Xu, Xiaoxu Ge, et al.. (2021). An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis. OncoImmunology. 10(1). 1901464–1901464. 16 indexed citations
9.
Xie, Haiting, Yurong Jiao, Jing Chen, et al.. (2021). Integrin αvβ6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway. Experimental Cell Research. 411(2). 113003–113003. 16 indexed citations
10.
Xu, Xiaoming, Shumei Wei, Yueming Chen, et al.. (2020). Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer. Disease Markers. 2020. 1–8. 9 indexed citations
11.
Li, Jun, Xinlin Li, Yu Tian, et al.. (2020). Abstract 4747: Genomic and transcriptomic landscape of AFP-producing gastrointestinal adenocarcinoma. Cancer Research. 80(16_Supplement). 4747–4747. 1 indexed citations
12.
Duan, Xiuzhi, Xiaoming Xu, Binbin Yin, et al.. (2019). The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy. Journal of Clinical Laboratory Analysis. 33(5). e22871–e22871. 8 indexed citations
13.
Chen, Jianguo, Xiaoming Xu, & Mingyu Fan. (2019). Inhibition of mitochondrial translation selectively targets osteosarcoma. Biochemical and Biophysical Research Communications. 515(1). 9–15. 9 indexed citations
14.
Chen, Jianguo, Jianguo Chen, Xiaoming Xu, Junjun Chen, & Junjun Chen. (2018). Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivity. Biochemical and Biophysical Research Communications. 506(3). 604–610. 16 indexed citations
15.
Fu, Jing, Huihui Ma, Xiaoming Xu, et al.. (2018). IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation. Blood Advances. 2(5). 492–504. 18 indexed citations
16.
Xin, Rui, et al.. (2017). Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway. BMC Complementary and Alternative Medicine. 17(1). 378–378. 87 indexed citations
17.
Song, Jukun, Dongbo Yuan, Xiaoming Xu, et al.. (2016). Association Between Cd Exposure and Risk of Prostate Cancer. Medicine. 95(6). e2708–e2708. 50 indexed citations
18.
Wang, Jingyu, et al.. (2016). Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review). International Journal of Oncology. 50(2). 345–355. 81 indexed citations
19.
Xu, Xiaoming, et al.. (2014). Association of xeroderma pigmentosum complementation group G Asp1104His polymorphism with breast cancer risk: A cumulative meta-analysis. Molecular and Clinical Oncology. 2(6). 1177–1181. 9 indexed citations
20.
Wu, Qiong, et al.. (2010). Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. European Journal of Cancer Prevention. 19(3). 186–194. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanen Yuan Breakdown of academic impact, for papers by Maria Concetta Faniello Breakdown of academic impact, for papers by Galina Khramtsova Breakdown of academic impact, for papers by Nikki P.Y. Lee Breakdown of academic impact, for papers by Wenzhi Shen Breakdown of academic impact, for papers by Krzysztof Goryca Breakdown of academic impact, for papers by Zhihui Min Breakdown of academic impact, for papers by Elham Baghbani Breakdown of academic impact, for papers by Han Yang Breakdown of academic impact, for papers by Ajay K. Yadav
Rankless by CCL
2026